Literature DB >> 9751411

Neurogenically mediated cystitis in rats: an animal model.

R Doggweiler1, L Jasmin, R A Schmidt.   

Abstract

PURPOSE: Pseudorabies virus (PRV) is a useful tool for mapping the control circuitry of the spinal cord. In the process of mapping CNS regulatory pathways for the lower urinary tract, a hemorrhagic change in the bladder was observed that was not overtly evident in other pelvic organs. The relationship between the appearance of hemorrhagic changes in the bladder and the evolution of PRV induced changes in the spinal cord was therefore explored.
MATERIALS AND METHODS: Sprague-Dawley rats were injected with PRV into the ACD tail-muscle. Bladder and CNS fixation were achieved by transcardial perfusion with formaldehyde. Multi-level sections were obtained from T8 through S4. Fixed tissue was stained and evaluated by light microscopy. Immunohistochemical stains were carried out for PRV and iNOS on spinal cord tissue. We were therefore able to evaluate the relationship between the manifestation of the hemorrhagic cystitis, appearance of the PRV in the spinal cord and evidence of CNS inflammation.
RESULTS: The evolution of hemorrhagic cystitis paralleled the evidence of inflammation in the thoraco-lumbar and sacral cord. These bladders contained 5 to 9 ml. of bloody urine (a normal rat bladder contains 1 to 2 ml.). On cystomanometry (CMG) the bladders were acontractile. No PRV could be cultured in the hemorrhagic bladders. The histological changes observed in the bladder represent true inflammation.
CONCLUSION: There was no obvious explanation for these changes other than the associated inflammatory changes in the spinal cord. The findings are consistent with the hypothesis that a spinal cord stress, via an unknown metabolic pathway, can result in dramatic, neurogenically mediated changes in the bladder.

Entities:  

Mesh:

Year:  1998        PMID: 9751411

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Interstitial cystitis: the painful bladder syndrome.

Authors:  R Doggweiler-Wiygul; J Blankenship; S A MacDiarmid
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Understanding multisymptom presentations in chronic pelvic pain: the inter-relationships between the viscera and myofascial pelvic floor dysfunction.

Authors:  Donna Hoffman
Journal:  Curr Pain Headache Rep       Date:  2011-10

Review 3.  Models of inflammation of the lower urinary tract.

Authors:  Dale E Bjorling; Zun-Yi Wang; Wade Bushman
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

Review 4.  Implications for bidirectional signaling between afferent nerves and urothelial cells-ICI-RS 2014.

Authors:  Anthony Kanai; Christopher Fry; Youko Ikeda; Florenta Aura Kullmann; Brian Parsons; Lori Birder
Journal:  Neurourol Urodyn       Date:  2016-02       Impact factor: 2.696

5.  FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.

Authors:  Kangmin D Lee; Woon N Chow; Carmen Sato-Bigbee; Martin R Graf; Robert S Graham; Raymond J Colello; Harold F Young; Bruce E Mathern
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 6.  Rehabilitation of the short pelvic floor. I: Background and patient evaluation.

Authors:  M P FitzGerald; R Kotarinos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-08-02

7.  Levator myalgia: why bother?

Authors:  Kerrie Adams; W Thomas Gregory; Blake Osmundsen; Amanda Clark
Journal:  Int Urogynecol J       Date:  2013-04-11       Impact factor: 2.894

Review 8.  Prostatitis: epidemiology of inflammation.

Authors:  Regula Doggweiler Wiygul
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

9.  Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.

Authors:  Charles N Rudick; Anthony J Schaeffer; David J Klumpp
Journal:  BMC Urol       Date:  2009-11-12       Impact factor: 2.264

10.  Mast cell-derived histamine mediates cystitis pain.

Authors:  Charles N Rudick; Paul J Bryce; Laura A Guichelaar; Ruth E Berry; David J Klumpp
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.